Uterine changes during tamoxifen, toremifene, and other therapy for breast cancer: Evaluation with magnetic resonance imaging

Japanese Journal of Radiology

Volumn 28, Issue 6, 2010, Pages 430-436

  Ochi, Junko ^a,b   Hayakawa, Katsumi ^b   Moriguchi, Yoshio ^b   Urata, Yoji ^b   Yamamoto, Akira ^c   Kawai, Kanae ^c  

^a KOBE CITY MEDICAL CENTER GENERAL HOSPITAL   (Japan)

^b KYOTO CITY HOSPITAL   (Japan)

^c KYOTO UNIVERSITY HOSPITAL   (Japan)

Author keywords

Endometrium; MRI; Tamoxifen; Toremifene

Indexed keywords

ALKYLATING AGENT; ANASTROZOLE; ANTHRACYCLINE; ANTINEOPLASTIC AGENT; EXEMESTANE; FLUOROURACIL; GOSERELIN; LEUPRORELIN; SELECTIVE ESTROGEN RECEPTOR MODULATOR; TAMOXIFEN; TAMOXIFEN CITRATE; TAXANE DERIVATIVE; TOREMIFENE;

ADULT; AGED; ARTICLE; BREAST CANCER; CLINICAL ARTICLE; DRUG EFFECT; DRUG USE; ENDOMETRIAL DISEASE; ENDOMETRIUM; ENDOMETRIUM THICKNESS; EVALUATION; FEMALE; HUMAN; IMAGE ANALYSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; POSTMENOPAUSE; PREMENOPAUSE; PRIORITY JOURNAL; PROSPECTIVE STUDY; SIDE EFFECT; THICKNESS;

ADULT; AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; ANTICARCINOGENIC AGENTS; AROMATASE INHIBITORS; BREAST NEOPLASMS; ENDOMETRIUM; FEMALE; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; MIDDLE AGED; POSTMENOPAUSE; PROSPECTIVE STUDIES; SELECTIVE ESTROGEN RECEPTOR MODULATORS; TAMOXIFEN; TOREMIFENE; UTERUS;

EID: 77955261937     PISSN: 18671071     EISSN: 1867108X     Source Type: Journal    
DOI: 10.1007/s11604-010-0446-9     Document Type: Article

References (24)

1. T. Utsumi N. Kobayashi H. Hanada 2007 Recent perspectives of endocrine therapy for breast cancer Breast Cancer 14 194 199 10.2325/jbcs.959 17485906
2. E. Senkus-Konefka T. Konefka J. Jassem 2004 The effects of tamoxifen on the female genital tract Cancer Treat Rev 30 291 301 10.1016/j.ctrv.2003.09.004 1:CAS:528:DC%2BD2cXivVKgu7k%3D 15059652 (Pubitemid 38477274)
3. S.A. Polin S.M. Ascher 2008 The effect of tamoxifen on the genital tract Cancer Imaging 8 135 145 10.1102/1470-7330.2008.0020 18603495 (Pubitemid 351936271)
4. M. Varras D. Polyzos C. Akrivis 2003 Effects of tamoxifen on the human female genital tract: review of the literature Eur J Gynaecol Oncol 24 258 268 1:STN:280:DC%2BD3s3nvFyitg%3D%3D 12807236
5. M.B. Marttunen B. Cacciatore P. Hietanen S. Pyrhonen A. Tiitinen T. Wahlstrom, et al. 2001 Prospective study on gynaecological effects of two antioestrogens tamoxifen and toremifene in postmenopausal woman Br J Cancer 84 897 902 10.1054/bjoc.2001.1703 1:CAS:528:DC%2BD3MXktVaqu7w%3D 11286468 (Pubitemid 32385831)
6. B. Fisher J.P. Costantino D.L. Wickerham R.S. Cecchini W.M. Cronin A. Robidoux, et al. 2005 Tamoxifen for the prevention of breast cancer: current status of the National Surgical Adjuvant Breast and Bowel Project P-1 study J Natl Cancer Inst 97 1652 1662 10.1093/jnci/dji372 1:CAS:528:DC%2BD2MXht1entb7L 16288118 (Pubitemid 41672231)
7. B. Gerber A. Krause T. Reimer I. Mylonas J. Makovitzky G. Kundt, et al. 2006 Anastrozole versus tamoxifen treatment in postmenopausal women with endocrine-responsive breast cancer and tamoxifen-induced endometrial pathology Clin Cancer Res 12 1245 1250 10.1158/1078-0432.CCR-05-0225 1:CAS:528: DC%2BD28XhsFaltLc%3D 16489080 (Pubitemid 43342515)
8. S. Gryspeerdt L. Van Hoe H. Bosmans A.L. Baert I. Vergote G. Marchal 1998 T2-weighted MR imaging of the uterus: comparison of optimized fast spin-echo and HASTE sequences with conventional fast spin-echo sequences AJR Am J Roentgenol 171 211 215 1:STN:280:DyaK1czhtFWhtw%3D%3D 9648791
9. K.M. Nalaboff J.S. Pellerito E. Ben-Levi 2001 Imaging the endometrium: disease and normal variants Radiographics 21 1409 1424 1:STN:280: DC%2BD3MnltlCntQ%3D%3D 11706213
10. S.P.S. Kochar P. Arora A.B. Chattopadhyay 2005 Tamoxifen therapy for breast cancer and endometrial pathology MJAFI 61 313 315
11. J. Geisler N. King M. Dowsett L. Ottestad S. Lundgren P. Walton, et al. 1996 Influence of anastrozole (Arimidex), a selective, non-steroidal aromatase inhibitor, on in vivo aromatisation and plasma oestrogen levels in postmenopausal women with breast cancer Br J Cancer 74 1286 1291 1:CAS:528:DyaK28Xnt1Shs7o%3D 8883419
12. S. Duffy T.L. Jackson M. Lansdown K. Philips M. Wells S. Pollard, et al. 2006 The ATAC ("Arimidex", Tamoxifen, Alone or in Combination) adjuvant breast cancer trial: first results of the endometrial sub-protocol following 2 years of treatment Hum Reprod 21 545 553 10.1093/humrep/dei322 1:CAS:528:DC%2BD28Xmslymtw%3D%3D 16210385 (Pubitemid 43159936)
13. G. Bertelli M. Venturini L. Del Mastro O. Garrone M. Cosso C. Gustavino, et al. 1998 Tamoxifen and the endometrium: findings of pelvic ultrasound examination Breast Cancer Res Treat 47 41 46 10.1023/A:1005820115535 1:CAS:528:DyaK1cXhs1agsbk%3D 9493974 (Pubitemid 28048149)
14. W.F. Cheng H.H. Lin P.L. Torng S.C. Huang 1997 Comparison of endometrial changes among symptomatic tamoxifen-treated and nontreated premenopausal and postmenopausal breast cancer patients Gynecol Oncol 66 233 237 10.1006/gyno.1997.4739 1:CAS:528:DyaK2sXlsV2nsLw%3D 9264568 (Pubitemid 27335409)
15. Y. Nakamura N. Furutani I. Tamura Y. Sanui M. Sayo K. Ueda 2006 The number of estrogen receptors on the uterus change with age Sanfujinkanojissai 55 2083 2086
16. M. Koshiyama M. Yoshida M. Takemura Y. Yura K. Matsushita M. Hayashi, et al. 1996 Immunohistochemical analysis of distribution of estrogen receptors and progesterone receptors in the postmenopausal endometrium Acta Obstet Gynecol Scand 75 702 706 10.3109/00016349609065730 1:STN:280:DyaK2s%2Fmt1amsQ%3D%3D 8906001
17. T. Hachisuga T. Hideshima T. Kawarabayashi F. Eguchi M. Emoto T. Shirakusa 1999 Expression of steroid receptors, Ki-67, and epidermal growth factor receptor in tamoxifentreated endometrium Int J Gynecol Pathol 18 297 303 10.1097/00004347-199910000-00002 1:STN:280:DC%2BD3c%2FhtVKnuw%3D%3D 10542936
18. M.L. Tregón J.E. Blümel J.J. Tarín A. Cano 2003 The early response of the postmenopausal endometrium to tamoxifen: expression of estrogen receptors, progesterone receptors, and Ki-67 antigen Menopause 10 154 159 10.1097/00042192-200310020-00007 12627041 (Pubitemid 36702703)
19. M.J. Mourits K.A. Ten Hoor A.G. van der Zee P.H. Willemse E.G. de Vries H. Hollema 2002 The effects of tamoxifen on proliferation and steroid receptor expression in postmenopausal endometrium J Clin Pathol 55 514 519 1:STN:280:DC%2BD38zlslentg%3D%3D 12101196
20. J.G. Klijn R.W. Blamey F. Boccardo T. Tominaga L. Duchateau R. Sylvester 2001 Combined tamoxifen and luteinizing hormonereleasing hormone (LHRH) agonist versus LHRH agonist alone in premenopausal advanced breast cancer: a meta-analysis of four randomized trials J Clin Oncol 19 343 353 1:CAS:528:DC%2BD3MXhtVekt74%3D 11208825
21. J. Weaver J.M. McHugo T.J. Clark 2005 Accuracy of transvaginal ultrasound in diagnosing endometrial pathology in women with post-menopausal bleeding on tamoxifen Br J Radiol 78 394 397 10.1259/bjr/60976544 1:STN:280: DC%2BD2M3htFWmug%3D%3D 15845930 (Pubitemid 40691740)
22. S.M. Ascher I. Imaoka J.M. Lage 2000 Tamoxifen-induced uterine abnormalities: the role of imaging Radiology 214 29 38 1:CAS:528: DC%2BD3cXlt12msQ%3D%3D 10644098
23. S.M. Ascher J.C. Johnson W.A. Barnes C.J. Bae R.H. Patt R.K. Zeman 1996 MR imaging appearance of the uterus in postmenopausal woman receiving tamoxifen therapy for breast cancer: histopathologic correlation Radiology 200 105 110 1:STN:280:DyaK283lslWntQ%3D%3D 8657895
24. ACOG committee opinion. No. 336: tamoxifen and uterine cancer. Obstet Gynecol 2006;107:1475-1478.